ZIPPER™ Stent-Graft Trial for Aortic Arch Dissection
ConditionDissection of Aortic Arch
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorHangzhou Endonom Medtech Co., Ltd.
About this trial
This study is the feasible study on a new technique of ZIPPER aortic arch stentgraft system
Eligibility criteria
Qualifiers
Age: 18-80 years of age.
Disqualifiers
Prior aortic intervention: History of open or endovascular repair of the descending or abdominal aorta.
Unruptured aneurysm ≥7 mm (anterior circulation) or ≥5 mm (posterior circulation)
Prior rupture or high-risk morphology (daughter sac, aspect ratio >1.6)
Intracranial arterial stenosis ≥50% with poor collateral flow. Contrast allergy. Pregnancy or lactation. Anesthesia/surgery contraindications: Severe comorbidities precluding tolerance to anesthesia or surgery.
Trial design
Treatments tested in this trial
- ZIPPER™ Stent-Graft Trial for Aortic Arch Dissection
Treatment groups
127 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov